在慢性心力衰竭患者中实施和评估医院到家庭的过渡性护理干预措施
Zhi-Fen Feng1, Yun Liu2, Jordan Tovera Salvador3
1School of Nursing and Health, Henan University, Kaifeng, China. fzf0315@126.com.
BMC nursing
|July 2, 2025
概括
过渡期护理可以提高慢性心力衰竭 (CHF) 患者的自我管理和生活质量. 这种医院到家庭的模式改善了紧急住院率,但并没有改善整体再入院率.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 护理 护理 护理
背景情况:
- 慢性心力衰竭 (CHF) 是一种严重的心血管疾病,死亡率高,预后不佳.
- 由于其复杂的性质和患者的症状,如软弱和运动能力下降,CHF的管理存在重大临床挑战.
- 有效的干预措施至关重要,以改善患者的治疗结果,并减少与CHF相关的医疗负担.
研究的目的:
- 调查慢性心力衰竭 (CHF) 患者从医院到家庭的过渡性护理的影响.
- 评估过渡期护理模型 (TCM) 在改善患者自我管理和临床结果方面的有效性.
- 为促进加强医疗保健政策促进CHF管理提供证据.
主要方法:
- 一项随机对照试验,涉及60名来自广东省第三级医院的CHF患者.
- 患者被分为干预组 (接受TCM专注的过渡期护理) 和对照组 (接受常规护理).
- 收集的数据包括自我有效性,自我管理,心脏超声波,血NT-proBNP水平,以及住院再接收/急诊率.
主要成果:
- 与对照组相比,干预组表现出明显改善的自我有效性和自我管理能力 (P < 0.05).
- 在干预组中观察到更好的心脏超声波结果和更低的血NT-proBNP水平 (P <0.05).
- 虽然整体医院再入院率没有显著差异,但干预组的紧急入院率明显较低 (P < 0.05).
结论:
- 医院到家庭的过渡护理,利用TCM,有效地增强自我管理,改善心血管疾病患者的生活质量.
- 该干预措施有望减少紧急医疗利用率,这是心血管疾病管理的关键方面.
- 这些发现支持将TCM纳入临床实践,并为未来的CHF患者的医疗保健政策制定提供信息.
相关概念视频
01:29Documentation in Long-Term and Home Healthcare Setting
994
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
994
01:30Heart Failure VII: Nursing Interventions
147
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
147
01:22Heart Failure VI: Adjunct Therapies
38
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
38
01:30Heart Failure IV: Classification and Diagnostic Evaluation
41
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
41
01:30Heart Failure V: Medical Management
33
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
33
01:27Heart Failure I: Introduction
75
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
75